MoneyWorks4Me

Biocon informs about updates

18 Feb 2025 Evaluate
Biocon has informed that it enclosed the company statement titled ‘European Commission Approves Biocon Biologics’ Ustekinumab Biosimilar’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..